Hyperinsulinemia Therapeutics Pipeline Analysis 2018

CITY, Country, 2019-Jul-26 — /EPR Network/ —

Hyperinsulinemia is a medical condition which is characterized by increased amount of insulin in blood. The primary cause of the disease is insulin resistance, which can also result in the development of type 2 diabetes.

Download the sample report at: https://www.pharmaproff.com/request-sample/1031

Insulinoma and nesidioblastosis are some other causes of hyperinsulinemia. Major symptoms of the disease are intense hunger, concentration difficulties, fatigue and obesity. People who have higher triglyceride and uric acid level, obesity, type 2 diabetes and hypertension are at a higher risk of developing hyperinsulinemia.

Get the detailed analysis at: https://www.pharmaproff.com/report/hyperinsulinemia-therapeutics-pipeline-analysis

Hanmi Pharmaceutical Co. Ltd. is currently developing HM15136, a long-acting glucagon analog, by using their LAPSCOVERY technology platform for the treatment of congenital hyperinsulinism. Moreover, Zealand Pharma A/S, and Heptares Therapeutics Ltd. are some other major companies involved in the development of therapeutic agents for the treatment of hyperinsulinemia.

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1031

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:

Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com

Web: https://www.pharmaproff.com

Connect with us on: LinkedIn | Twitter | Facebook